ARCHIVES

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Drugs Available To Investigators Centers to Monitor Them Are Listed

September 9, 1977

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

NIH Deputy Director Ruth Kirschstein Plans Transition To Senior Advisor

October 4, 2002

Hollings Cancer Center at MUSC Wins NCI Designation

March 6, 2009

Phase II Study Tests Chemo Plus Mylotarg For AML

December 27, 2002